rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christopher Paul Simms

Officer

Company insider

Files Form 4 as: Officer, 4D Molecular Therapeutics; SVP, Chief Commercial Officer, IVERIC bio.

Every Form 4 they filed

In numbers

Trades disclosed
26
Buys
1
Sells
2
Bought
$50K
Sold
$186K
Companies
2
Companies where not an officer
0
First trade
2 Aug 2021
Last trade
25 Mar 2026
Last filed
27 Mar 2026

Companies traded

Where they are an officer
FDMT 4D Molecular TherapeuticsOfficer · Biotechnology · last 25 Mar 20260 buys · 0 sells
IVERIC bioOfficer · last 11 Jul 20231 buy · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
25 Mar 2026filed 27 Mar 2026FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—219,000 at $0.00filing
25 Mar 2026filed 27 Mar 2026FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—219,000 at $0.00filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—56,250filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—18,750filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—37,500filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—160,000filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—50,000filing
11 Jul 2023filed 13 Jul 2023IVERIC biooption or derivativeSEC FORM 4 Code D—75,000filing
11 Jul 2023filed 13 Jul 2023IVERIC bioSEC FORM 4 Code D—32,429filing
3 Jan 2023filed 4 Jan 2023IVERIC bioSEC FORM 4 Sold$48K2,368 at $20.06filing
2 Jan 2023filed 4 Jan 2023IVERIC biooption or derivativeSEC FORM 4 Code M—6,250 at $0.00filing
2 Jan 2023filed 4 Jan 2023IVERIC bioSEC FORM 4 Code M—6,250 at $0.00filing
20 Dec 2022filed 22 Dec 2022IVERIC biooption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
20 Dec 2022filed 22 Dec 2022IVERIC biooption or derivativeSEC FORM 4 Code A—37,500 at $0.00filing
3 Aug 2022filed 4 Aug 2022IVERIC bioSEC FORM 4 Sold$61K5,454 at $11.25filing
3 Aug 2022filed 4 Aug 2022IVERIC bioSEC FORM 4 Sold$77K6,818 at $11.25filing
2 Aug 2022filed 4 Aug 2022IVERIC biooption or derivativeSEC FORM 4 Code M—15,000 at $0.00filing
2 Aug 2022filed 4 Aug 2022IVERIC biooption or derivativeSEC FORM 4 Code M—18,750 at $0.00filing
2 Aug 2022filed 4 Aug 2022IVERIC bioSEC FORM 4 Code M—15,000 at $0.00filing
2 Aug 2022filed 4 Aug 2022IVERIC bioSEC FORM 4 Code M—18,750 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Scott BizilyChief Legal Officer · Chief Legal Officer at 4D Molecular Therapeutics, filing Form 4 there in the last year
David KirnDirector and Officer · Director and Officer at 4D Molecular Therapeutics, filing Form 4 there in the last year
Jacob ChackoDirector · Director at 4D Molecular Therapeutics, filing Form 4 there in the last year
Shawn TomaselloDirector · Director at 4D Molecular Therapeutics, filing Form 4 there in the last year
Charles TheuerDirector · Director at 4D Molecular Therapeutics, filing Form 4 there in the last year